Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00010829 · ClinicalTrials.gov registry record · Phase 2
Macrobiotic Diet and Flax Seed: Effects on Estrogens, Phytoestrogens, & Fibrinolytic Factors
A Phase 2 study, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- Completed
- Registry status
- Phase 2
- Development phase
NCT00010829: Completed Phase 2 study, sponsored by National Center for Complementary and Integrative Health (NCCIH).
NCT00010829 is a Phase 2 study that has completed, run by National Center for Complementary and Integrative Health (NCCIH). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00010829, a Phase 2 study, has completed, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
This study will assess whether alternative, high phytoestrogen dietary interventions result in favorable effects on biological parameters that have been associated with hormone-dependent cancers, cardiovascular disease, and osteoporosis.
Interventions
- BEHAVIORAL American Heart Association Step 1 diet
- BEHAVIORAL American Heart Association Step 2 diet + 10 g/day flax seed
- BEHAVIORAL Macrobiotic dietary intervention
Trial Details
| Field | Value |
|---|---|
| Start Date | 2001-01 |
| Est. Completion | 2005-12 |
| Phase | Phase 2 |
What the finished NCT00010829 record still lists
NCT00010829 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 3 interventions - of which American Heart Association Step 1 diet is the first listed.
NCT00010829 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00010829 about?
NCT00010829 is a clinical study titled "Macrobiotic Diet and Flax Seed: Effects on Estrogens, Phytoestrogens, & Fibrinolytic Factors". This study will assess whether alternative, high phytoestrogen dietary interventions result in favorable effects on biological parameters that have been associated with hormone-dependent cancers, cardiovascular disease, and osteoporosis.
What is the current status of trial NCT00010829?
This trial is currently completed. It is a Phase 2 study. The study started on 2001-01. Estimated completion is 2005-12.
What interventions are being tested in trial NCT00010829?
The interventions under investigation include: American Heart Association Step 1 diet (BEHAVIORAL), American Heart Association Step 2 diet + 10 g/day flax seed (BEHAVIORAL), Macrobiotic dietary intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT00010829?
This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia